Learn about Concerta 18 mg ER, a medication used to treat ADHD. Discover its benefits, dosage, side effects and more in this informative article.

Learn about Concerta 18mg ER, a medication used to treat ADHD. Discover its benefits, dosage, side effects and more in this informative article.

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity. People diagnosed with ADHD often face challenges in various aspects of their lives, including academic, social, and occupational realms. Concerta 18 mg ER, an extended-release formulation of methylphenidate, has become one of the most prescribed medications to treat ADHD symptoms in both children and adults.

Methylphenidate, the active ingredient in Concerta 18 mg ER, belongs to a class of medications known as stimulants. Stimulants work by affecting certain chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Concerta 18mg ER is specifically designed to provide a gradual and sustained release of the medication throughout the day, offering a consistent therapeutic effect.

Important information:

  • Concerta 18mg ER should only be taken as prescribed by a healthcare professional.
  • It is essential to carefully follow dosage instructions and not alter the medication without consulting your doctor.
  • This medicine is not suitable for people with a history of heart problems, high blood pressure, or hyperthyroidism.

Concerta 18 mg ER is available in tablet form and its extended-release formulation allows for once-daily dosing, promoting convenience and compliance with the treatment plan. The 18 mg dose is often considered an initial starting point for patients starting Concerta or for those with milder ADHD symptoms. However, dosage adjustment may be necessary based on individual response and health care professional assessment.

Concerta 18mg ER: Main Features
Tradename Generic name Dose Release mechanism
Concerta Methylphenidate ER 18mg Extended release

Author of the article
Dr.Greenblatt M.
Dr.Greenblatt M.
Medical oncologist at the Robert Larner College of Medicine, MD, at the University of Vermont

Cannabis and Hemp Testing Laboratory
Add a comment